drugset / Trial / NCT06209879

Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis

NCT06209879 ↗

Phase 4 Unknown 40 enrolled Chang Gung Memorial Hospital
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the efficacy of hydroxypropyl guar-and hyaluronic acid containing lubricant eye drops in rheumatoid arthritis patients . The main question it aims to answer is: • whether adding hydroxypropyl guar-and hyaluronic acid containing lubricant eye drops to steroid-based dry eye therapy improves dry eye symptoms in rheumatoid arthritis patients after 1 month. Participants with rheumatoid arthritis will be treat with SYSTANE™ Hydration Lubricant Eye Drops (1-2 drops 4 times a day) and 0.1% Fluorometholone (1-2 drops 3 times a day) in both eyes for 12 weeks

Timeline

Start
2024-02-05
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SYSTANE™ Hydration Lubricant Eye Drops Unknown 0.15 % Topical
Subject SYSTANE™ Hydration Lubricant Eye Drops Unknown 0.3 % Topical
Subject SYSTANE™ Hydration Lubricant Eye Drops Unknown 0.4 % Topical
Background 0.1% FML Unknown 0.1 % Topical

Indications